Nasrin Haghani: How Vitamin K2 Reduces Arterial Plaque Buildup and Promotes Heart Health
Nasrin Haghani, Surgical Lead Technician at Nuvia Dental Implant Center, shared a post on LinkedIn:
”Vitamin K2 has been gaining attention for its cardiovascular benefits, particularly in supporting arterial health. Research indicates that taking 90 micrograms daily over a nine-month period slowed plaque buildup in the carotid artery by more than 55 percent. This effect is believed to result from vitamin K2’s ability to activate proteins that help direct calcium away from the arteries and into bones, reducing arterial stiffness and promoting heart health. Healthy calcium metabolism is critical for preventing hardening of the arteries and maintaining efficient blood flow.
Beyond plaque reduction, vitamin K2 supports vascular flexibility and overall cardiovascular resilience. By preventing calcium from depositing in blood vessels, it reduces the risk of atherosclerosis, hypertension, and related complications. The nutrient also works synergistically with vitamin D and magnesium, enhancing calcium regulation and contributing to bone strength while protecting the circulatory system. These dual benefits make vitamin K2 a key player in maintaining long-term heart and bone health simultaneously.
Incorporating vitamin K2 can be done through supplements or K2-rich foods such as natto, certain cheeses, and egg yolks. While it’s not a substitute for a heart-healthy lifestyle, consistent intake alongside proper diet, regular exercise, and stress management may amplify cardiovascular protection. Small, consistent nutritional strategies like this demonstrate how targeted nutrients can influence long-term arterial health and overall vitality.”

Stay updated with Hemostasis Today.
-
Jul 14, 2026, 15:27Dianne E Van Der Wal: Celebrating Scientific Contributions at ISTH 2026
-
Jul 14, 2026, 15:13Alfonso Tafur: RIETE Registry Analysis Supports More Equitable Approaches to VTE Care
-
Jul 14, 2026, 15:03Heghine Khachatryan: Phase III Trial Results Support BAFF-R Inhibition in Corticosteroid-Refractory ITP
-
Jul 14, 2026, 14:51Nathan Connell: ISTH 2026 Highlights the Power of Lifelong Collaboration
-
Jul 14, 2026, 14:42Wolfgang Miesbach: VOYAGER1 Highlights Progress Toward Injection-Free Care in Hemophilia A
-
Jul 14, 2026, 12:08Elvira Grandone: Finding the Right LMWH Dose for Pregnant Patients Suffering From DVT
-
Jul 14, 2026, 12:05Eloïse Laouenan: From Washington to Paris – Join GETBO at ISTH 2026
-
Jul 14, 2026, 12:02Louise St. Germain Bannon: Our first ISTH regulatory session at ISTH 2026
-
Jul 14, 2026, 11:21Malwina Maliszewska: Advancing Coagulation Diagnostics at ISTH 2026